Pioglitazone has favourable long-term risk benefit profile: TGA

The review, published in the latest Medicines Safety Update, was prompted by research in 2011 linking long-term use of pioglitazone to an increased risk of bladder cancer as well as ongoing safety concerns with another drug in the class, rosiglitazone.

# Tags